[HTML][HTML] Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond

JL Karnell, SA Rieder, R Ettinger, R Kolbeck - Advanced drug delivery …, 2019 - Elsevier
CD40 is a TNF receptor superfamily member expressed on both immune and non-immune
cells. Interactions between B cell-expressed CD40 and its binding partner, CD40L …

Immune Checkpoint Therapies and Atherosclerosis: Mechanisms and Clinical Implications: JACC State-of-the-Art Review

JT Vuong, AF Stein-Merlob, A Nayeri, T Sallam… - Journal of the American …, 2022 - jacc.org
Immune checkpoint inhibitor therapy has revolutionized the treatment of advanced
malignancies in recent years. Numerous reports have detailed the myriad of possible …

Activation and regulation of alloreactive T cell immunity in solid organ transplantation

C Duneton, PD Winterberg, ML Ford - Nature Reviews Nephrology, 2022 - nature.com
Transplantation is the only curative treatment for patients with kidney failure but it poses
unique immunological challenges that must be overcome to prevent allograft rejection and …

Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease

M Lacy, C Bürger, A Shami, M Ahmadsei… - Nature …, 2021 - nature.com
Atherosclerosis is a major underlying cause of cardiovascular disease. Previous studies
showed that inhibition of the co-stimulatory CD40 ligand (CD40L)-CD40 signaling axis …

Agonistic CD40 antibodies in cancer treatment

D Djureinovic, M Wang, HM Kluger - Cancers, 2021 - mdpi.com
Simple Summary CD40 is a costimulatory molecule that is key for the activation of antigen-
presenting cells and other innate immune cells. It plays an important role in anti-tumor …

Biomimetic nanoparticle technology for cardiovascular disease detection and treatment

JH Park, D Dehaini, J Zhou, M Holay, RH Fang… - Nanoscale …, 2020 - pubs.rsc.org
Cardiovascular disease (CVD), which encompasses a number of conditions that can affect
the heart and blood vessels, presents a major challenge for modern-day healthcare. Nearly …

CD40–CD40L in neurological disease

HD Ots, JA Tracz, KE Vinokuroff, AE Musto - International Journal of …, 2022 - mdpi.com
Immune-inflammatory conditions in the central nervous system (CNS) rely on molecular and
cellular interactions which are homeostatically maintained to protect neural tissue from …

Role of CD39 in COVID-19 severity: dysregulation of purinergic signaling and thromboinflammation

E Díaz-García, S García-Tovar, E Alfaro… - Frontiers in …, 2022 - frontiersin.org
CD39/NTPDase1 has emerged as an important molecule that contributes to maintain
inflammatory and coagulatory homeostasis. Various studies have hypothesized the possible …

Platelets as therapeutic targets to prevent atherosclerosis

H Nording, L Baron, HF Langer - Atherosclerosis, 2020 - Elsevier
Cardiovascular disease remains the main cause of death worldwide. For this reason,
strategies for the primary prevention of atherosclerosis and atherosclerosis-related …

Platelet biology and function: Plaque erosion vs. rupture

CC Baaten, M Nagy, W Bergmeier… - European Heart …, 2024 - academic.oup.com
The leading cause of heart disease in developed countries is coronary atherosclerosis,
which is not simply a result of ageing but a chronic inflammatory process that can lead to …